In the era of data-driven planning transformation, precision is key! 🎯

At EyeOn, we teamed up with Johnson & Johnson Innovative Medicine to revolutionize their Planning Sensitive Parameters (PSP).

Johnson & Johnson Innovative Medicine recognized the need for standardized, dynamic, and time-efficient PSP reviews. These critical parameters are the foundation of planning, high quality data significantly improves planning accuracy and delivers tangible business savings.

👉 Together with the Johnson & Johnson GPEX and Digital Team and in close collaboration with Bert Jacobs, João Viegas, Can L. Ünal, Sophie Closs, Debora Cesareo, and cross-functional business leaders (planning, quality, make, deliver) we developed a global scalable tool and standardized review process that delivered solid results:

📈 10x Efficiency Boost
🌐 Global Harmonization
🔍 Actionable Insights
📊 Enhanced Data Quality
📦 Inventory Savings

Learn more about our collaborative journey to reach these achievements here 🔗: https://lnkd.in/euJUUaBr